Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stratigos

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
The British Journal of Dermatology|September 24, 2019
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT studyR Dummer, A Guminksi, R Gutzmer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 9, 2026
Age-specific melanoma risk associated with nevi: a pooled analysis from the M-SKIP projectGiulia Doi, Aurora Gaeta, Simone Ribero, et al.
European Journal of Human Genetics : EJHG|February 6, 2019
Case-control analysis identifies shared properties of rare germline variation in cancer predisposing genesMykyta Artomov, Vijai Joseph, Grace Tiao, et al.
Journal of the American Academy of Dermatology|September 8, 2022
The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infectionsEsther E Freeman, Cristina Galvan Casas, Sonya Prasad, et al.
Future Oncology (London, England)|July 29, 2024
Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trialAlexander J Stratigos, Chieh-I Chen, Cristina Ivanescu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
Journal of the American Academy of Dermatology|December 6, 2020
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) groupVasiliki Nikolaou, Vincent Sibaud, Davide Fattore, et al.
Journal of the American Academy of Dermatology|March 21, 2024
Germline cancer susceptibility in individuals with melanomaPauline Funchain, Ying Ni, Brandie Heald, et al.
Experimental Gerontology|August 15, 2002
Ageing research in GreeceE S Gonos, D Agrafiotis, A S Dontas, et al.
Cancers|July 29, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International StudyPietro Sollena, Nikolaou Vasiliki, Elias Kotteas, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
The British Journal of Dermatology|September 24, 2019
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT studyR Dummer, A Guminksi, R Gutzmer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 9, 2026
Age-specific melanoma risk associated with nevi: a pooled analysis from the M-SKIP projectGiulia Doi, Aurora Gaeta, Simone Ribero, et al.
European Journal of Human Genetics : EJHG|February 6, 2019
Case-control analysis identifies shared properties of rare germline variation in cancer predisposing genesMykyta Artomov, Vijai Joseph, Grace Tiao, et al.
Journal of the American Academy of Dermatology|September 8, 2022
The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infectionsEsther E Freeman, Cristina Galvan Casas, Sonya Prasad, et al.
Future Oncology (London, England)|July 29, 2024
Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trialAlexander J Stratigos, Chieh-I Chen, Cristina Ivanescu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
Journal of the American Academy of Dermatology|December 6, 2020
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) groupVasiliki Nikolaou, Vincent Sibaud, Davide Fattore, et al.
Journal of the American Academy of Dermatology|March 21, 2024
Germline cancer susceptibility in individuals with melanomaPauline Funchain, Ying Ni, Brandie Heald, et al.
Experimental Gerontology|August 15, 2002
Ageing research in GreeceE S Gonos, D Agrafiotis, A S Dontas, et al.
Cancers|July 29, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International StudyPietro Sollena, Nikolaou Vasiliki, Elias Kotteas, et al.
Pageof 24